Employees: 51-200
Founded date: 2005
Investors 1
| Date | Name | Website |
| - | LaunchCyte | launchcyte... |
Mentions in press and media 3
| Date | Title | Description |
| 14.11.2012 | Drug developer advancing Phase 2 drug for Lou Gehrig’s disease raises $15M | Product: Its lead product is dexpramipexole for amyotrophic lateral sclerosis or Lou Gehrig’s disease and is being developed with Biogen. It is designed to protect stressed neurons and other cell types from dying, according to its website. ... |
| 15.08.2007 | Life sciences briefing: Wednesday, Aug. 15, 2007 | (UPDATED at 5:55pm PT: See below.) Featured companies: Sierra Surgical Technologies, HerbalScience Nutraceuticals, Topigen Pharmaceuticals, EKR Therapeutics, Molecular Partners, Celsense, Glucose Sensing Technologies, Falcon Genomics, Water... |
| - | Drug developer advancing Phase 2 drug for Lou Gehrig’s disease raises $15M | Company name: Knopp Biosciences Industry: Biotechnology Location: Pittsburgh, Pennsylvania Product: Its lead product is dexpramipexole for amyotrophic lateral sclerosis or Lou Gehrig’s disease and is being developed with Biogen. It is desig... |